Patents Assigned to Imedex Biomateriaux
  • Patent number: 6730299
    Abstract: A biocompatible fluid adhesive protein foam, which is bioresorbable and nontoxic, for surgical and/or therapeutic use, in particular for protecting/cicatrizing tissue wounds and for attaching biological tissues to each other or to an implanted biomaterial. The biocompatible fluid adhesive protein foam includes a biocompatible fluid adhesive protein matrix, which is bioresorbable and nontoxic, containing a biocompatible and nontoxic gas or mixture of gases. Further, a process and a kit for preparing such a foam are provided.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: May 4, 2004
    Assignee: Imedex Biomateriaux
    Inventors: Jean-Louis Tayot, Yves Bayon, Philippe Gravagna, Michel Marie Dubois
  • Patent number: 6706684
    Abstract: The invention concerns a method for preparing a non-toxic, sterile, biocompatible, crosslinked collagen material with controlled in vivo biodegradation speed. It consists in subjecting a collagen constituent, either to beta radiation, or to gamma radiation. The collagen material obtained is biodegradable in a few days depending on the type of irradiation used.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: March 16, 2004
    Assignee: Imedex Biomateriaux
    Inventors: Yves Bayon, Philippe Gravagna, Jean-Louis Tayot
  • Patent number: 6605066
    Abstract: A device for the formation and delivery of a mixture, notably a surgical adhesive, consisting of a receptacle adapted for easy handling by the surgeon, and including the means of receiving two syringe barrels containing the constituents of the mixture, the means of simultaneously expelling the contents, the means of maintaining the contents of syringe containing the first constituent, at a predetermined temperature setting which is higher than body temperature, and a mixer simultaneously receiving the contents of the two syringes, and the mixer also being used for cooling.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: August 12, 2003
    Assignee: Imedex Biomateriaux
    Inventors: Philippe Gravagna, Jean-Louis Tayot
  • Patent number: 6596304
    Abstract: A bicomposite material based on collagen is prepared which has two closely bound layers and is biocompatible, non-toxic, hemostatic and biodegradable in less than a month, and can be used in surgery to achieve hemostasis and prevent post-surgical adhesion. To prepare the material, a solution of collagen or gelatin, which may contain glycerine and a hydrophilic additive such as polyethylene glycol or a polysaccharide, is poured onto an inert support to form a layer 30 &mgr;m to less than 100 &mgr;m thick. Then a polymeric porous fibrous layer is applied during gelling of the collagen or gelatin, and the resultant material is dried. The polymeric porous fibrous layer may be made of collagen or a polysaccharide, and have a density of not more than 75 mg/cm2, a pore size from 30 &mgr;m to 300 &mgr;m and a thickness of 0.2 cm to 1.5 cm.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: July 22, 2003
    Assignee: Imedex Biomateriaux
    Inventors: Yves Bayon, Philippe Gravagna, Jean-Lois Tayot
  • Patent number: 6451032
    Abstract: The composite prosthesis comprises a prosthetic fabric having a three-dimensional structure separating two surfaces, one of which is open to post-surgical cell colonization. The composite prosthesis further comprises at least one film of a collagenous material linked to the other surface of the prosthetic fabric. The composite prosthesis may be used to prevent post-surgical adhesion.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: September 17, 2002
    Assignees: Sofradim Production, Imedex Biomateriaux
    Inventors: François Régis Ory, Michel Therin, Philippe Gravagna, Jean-Louis Tayot
  • Patent number: 6391939
    Abstract: The present invention relates to a biocompatible collagenous material which is non-toxic and biodegradable in less than one month, preferably in less than one week. This material comprises collagen and at least one hydrophilic macromolecular additive which is chemically non-reactive towards the collagen, with the collagen having at least partially lost its helical structure and being crosslinked. The invention also relates to a process for obtaining such a material. The collagenous material according to the invention is used, in particular, for preventing post-operative adhesions.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: May 21, 2002
    Assignee: Imedex Biomateriaux
    Inventors: Jean-Louis Tayot, Michel Tardy, Philippe Gravagna
  • Patent number: RE39172
    Abstract: A bicomposite material based on collagen is prepared which has two closely bound layers and is biocompatible, non-toxic, hemostatic and biodegradable in less than a month, and can be used in surgery to achieve hemostasis and prevent post-surgical adhesion. To prepare the material, a solution of collagen or gelatin, which may contain glycerine and a hydrophilic additive such as polyethylene glycol or a polysaccharide, is poured onto an inert support to form a layer 30 ?m to less than 100 ?m thick. Then a polymeric porous fibrous layer is applied during gelling of the collagen or gelatin, and the resultant material is dried. The polymeric porous fibrous layer may be made of collagen or a polysaccharide, and have a density of not more than 75 mg/cm2, a pore size from 30 ?m to 300 ?m and a thickness of 0.2 cm to 1.5 cm.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: July 11, 2006
    Assignee: Imedex Biomateriaux
    Inventors: Yves Bayon, Philippe Gravagna, Jean-Louis Tayot